A new lab method keeps brain tumor tissue alive for 28 days
Original title: A long-term organotypic slice culture model of patient high-grade glioma preserving tumor heterogeneity and architecture, and specificity of CAR T cell targeting
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only done with tumor tissue in a lab dish.
The short version
Scientists kept slices of patients' brain tumors alive in the lab for 28 days.
What was studied. Researchers took tumor tissue from people with a fast growing brain tumor called high grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary. They cut it into thin slices and grew the slices in the lab. Then they checked how much the slices still matched the tumors they came from.
What they found. The slices kept the same mix of cells and the same structure for at least 28 days. They also kept the same targets that immune treatments aim at. When CAR T cells were added, they killed the right target cells, like they did in the original tumors.
What this means, and what it doesn't
What it could mean: Labs may get a better way to test new treatments before trying them in people. That could help researchers pick which ideas are worth testing next.
What it doesn't mean: This is not a treatment. The work was done on tumor tissue in a lab dish, not in people. No one was treated and no one got better. It does not show that CAR T cells help patients. It is not a cure, and it is a long way from everyday care.
Source: bioRxiv (preprint), October 6, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.